Literature DB >> 20975276

Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians.

Heino Stöver1.   

Abstract

BACKGROUND/AIMS: Although the number of patients in opioid substitution treatment (OST) in Germany has increased in recent years, many dependent opioid users remain out of treatment. Project IMPROVE assessed attitudes and beliefs regarding barriers to OST.
METHODS: Data were collected from opioid-dependent individuals (using self-complete questionnaires) currently in treatment (n = 200) or not in treatment (n = 200), and OST-accredited physicians (using computer-aided telephone interviewing) who currently provided (n = 101) or did not provide OST (n = 51) from different regions in Germany.
RESULTS: Key results showed that OST was perceived as valuable and effective by physicians, patients and users but that OST access and provision were inadequate, especially outside of major cities.
CONCLUSION: These findings are consistent with national data indicating a worsening imbalance between patient demand for treatment and the supply of available physicians accredited to provide it. Many physicians and patients were not aware of, or were not utilizing, therapeutic strategies that may help reduce misuse and diversion. Improvements in the regulatory framework for OST, and identifying additional sources of support and training, would encourage more accredited physicians to actively provide treatment and thus help to fully realize the benefits of currently available treatment options.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20975276     DOI: 10.1159/000320576

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  23 in total

1.  Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.

Authors:  Elizabeth Bromley; Derjung M Tarn; Michael McCreary; Brian Hurley; Allison J Ober; Katherine E Watkins
Journal:  J Subst Abuse Treat       Date:  2020-04-20

2.  Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.

Authors:  Samara Mayer; Al Fowler; Isabella Brohman; Nadia Fairbairn; Jade Boyd; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-09-16

3.  Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.

Authors:  Robert D Ashford; Austin M Brown; Jessica McDaniel; Jenna Neasbitt; Chad Sobora; Robert Riley; Lesley Weinstein; Aaron Laxton; Justin Kunzelman; Kyle Kampman; Brenda Curtis
Journal:  Addict Behav       Date:  2019-06-21       Impact factor: 3.913

4.  Monitoring opioid addiction and treatment: Do you know if your population is engaged?

Authors:  José Tomás Prieto; Dean McEwen; Arthur J Davidson; Alia Al-Tayyib; Lisa Gawenus; Sridhar R Papagari Sangareddy; Joshua Blum; Seth Foldy; Judith C Shlay
Journal:  Drug Alcohol Depend       Date:  2019-07-06       Impact factor: 4.492

Review 5.  Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Authors:  Elizabeth M Oliva; Natalya C Maisel; Adam J Gordon; Alex H S Harris
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

6.  Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Maxim Polonsky; Ruthanne Marcus; Martha J Bojko; Sergii Filippovych; Sandra Springer; Sergii Dvoriak; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2016-06-17       Impact factor: 4.492

Review 7.  A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Authors:  Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

8.  Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.

Authors:  Torkel Richert; Björn Johnson
Journal:  Harm Reduct J       Date:  2015-02-18

9.  Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.

Authors:  Dennis P Watson; Tess Weathers; Alan McGuire; Alex Cohen; Philip Huynh; Clay Bowes; Daniel O'Donnell; Krista Brucker; Sumedha Gupta
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

10.  Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.

Authors:  Bernd Schulte; Christiane Sybille Schmidt; Olaf Kuhnigk; Ingo Schäfer; Benedikt Fischer; Heiner Wedemeyer; Jens Reimer
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.